Guardant Health Stock Technical Analysis

GH Stock  USD 117.03  2.28  1.99%   
As of the 26th of January, Guardant Health retains the market risk adjusted performance of 2.81, and Risk Adjusted Performance of 0.1504. Guardant Health technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Guardant Health Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Guardant, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to GuardantGuardant Health's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Guardant Health Analyst Consensus

Target PriceAdvice# of Analysts
121.19Strong Buy24Odds
Guardant Health current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Guardant analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Guardant stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Guardant Health, talking to its executives and customers, or listening to Guardant conference calls.
Guardant Analyst Advice Details
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.22)
Revenue Per Share
7.27
Quarterly Revenue Growth
0.385
Return On Assets
(0.20)
Return On Equity
(45.84)
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Guardant Health 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Guardant Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Guardant Health.
0.00
10/28/2025
No Change 0.00  0.0 
In 3 months and 1 day
01/26/2026
0.00
If you would invest  0.00  in Guardant Health on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding Guardant Health or generate 0.0% return on investment in Guardant Health over 90 days. Guardant Health is related to or competes with EXACT Sciences, ICON PLC, Revvity, Ascendis Pharma, Viatris, Qiagen NV, and Ionis Pharmaceuticals. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States... More

Guardant Health Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Guardant Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Guardant Health upside and downside potential and time the market with a certain degree of confidence.

Guardant Health Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Guardant Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Guardant Health's standard deviation. In reality, there are many statistical measures that can use Guardant Health historical prices to predict the future Guardant Health's volatility.
Hype
Prediction
LowEstimatedHigh
110.42114.75119.08
Details
Intrinsic
Valuation
LowRealHigh
114.33118.66122.99
Details
Naive
Forecast
LowNextHigh
113.33117.66121.99
Details
24 Analysts
Consensus
LowTargetHigh
110.28121.19134.52
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Guardant Health. Your research has to be compared to or analyzed against Guardant Health's peers to derive any actionable benefits. When done correctly, Guardant Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Guardant Health.

Guardant Health January 26, 2026 Technical Indicators

Guardant Health Backtested Returns

Guardant Health appears to be very steady, given 3 months investment horizon. Guardant Health holds Efficiency (Sharpe) Ratio of 0.21, which attests that the entity had a 0.21 % return per unit of standard deviation over the last 3 months. By evaluating Guardant Health's technical indicators, you can evaluate if the expected return of 0.91% is justified by implied risk. Please utilize Guardant Health's market risk adjusted performance of 2.81, and Risk Adjusted Performance of 0.1504 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Guardant Health holds a performance score of 16. The company retains a Market Volatility (i.e., Beta) of 0.29, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Guardant Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Guardant Health is expected to be smaller as well. Please check Guardant Health's semi deviation, sortino ratio, semi variance, as well as the relationship between the standard deviation and value at risk , to make a quick decision on whether Guardant Health's current trending patterns will revert.

Auto-correlation

    
  0.54  

Modest predictability

Guardant Health has modest predictability. Overlapping area represents the amount of predictability between Guardant Health time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Guardant Health price movement. The serial correlation of 0.54 indicates that about 54.0% of current Guardant Health price fluctuation can be explain by its past prices.
Correlation Coefficient0.54
Spearman Rank Test0.72
Residual Average0.0
Price Variance39.35
Guardant Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Guardant Health technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Guardant Health trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Guardant Health Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Guardant Health volatility. High ATR values indicate high volatility, and low values indicate low volatility.

About Guardant Health Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Guardant Health on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Guardant Health based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Guardant Health price pattern first instead of the macroeconomic environment surrounding Guardant Health. By analyzing Guardant Health's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Guardant Health's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Guardant Health specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 2025 (projected)
Payables Turnover4.397.528.64
Days Of Inventory On Hand99.5989.5380.58

Guardant Health January 26, 2026 Technical Indicators

Most technical analysis of Guardant help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Guardant from various momentum indicators to cycle indicators. When you analyze Guardant charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Guardant Health January 26, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Guardant stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for Guardant Stock analysis

When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Commodity Directory
Find actively traded commodities issued by global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes